Bittium Oyj provides solutions for communications and connectivity, healthcare technology products and services, and biosignal measuring and monitoring in Finland, Germany, and the United States. It offers medical technologies products and solutions, including holter, long-term cardiac, and cardiac event monitoring; mobile cardiac telemetry; tools for biosignal analysis; medical service platform solutions; home sleep apnea testing; EEG monitoring for ICU and ER; and neuroscientific research, as well as Bittium Faros, HolterPlus, MedicalSuite, cardiac navigator, ECG electrodes, Respiro, BrainStatus, and NeurOne. The company also provides engineering services, such as industrial IoT, radio unit, medical and healthcare, mobiles devices, and mobile satellite communications; and system and architecture design, electronics, mechanics, RF and antenna design, software development, product testing and verification, DevOps, and certified management systems, as well as cellular IoT solution. In addition, it offers tactical and secure communications system. Further, it provides product development services in the areas of wireless telecommunications, medical technology, connected vehicles, and manufacturing industries; and offers healthcare technology products and services in biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health, and sports medicine. The company’s solutions are used for customers in the defense, security, and public safety markets. The company was formerly known as Elektrobit Corporation and changed its name to Bittium Oyj in July 2015. Bittium Oyj was founded in 1985 and is headquartered in Oulu, Finland.
